A Causal Inference Approach to Mediation Analysis in Vitreomacular Traction: How Much Does Traction Resolution...

Area of Science:

• Ophthalmology
• Clinical Trials
• Biostatistics

Background:

• Mediation analysis enhances understanding of treatment mechanisms beyond intention-to-treat analysis.
• Vitreomacular adhesion resolution (VMAR) is an anatomic marker potentially mediating vision benefits.
• Ocriplasmin is a therapeutic agent used for vitreomacular traction.

Purpose of the Study:

• To investigate the extent to which VMAR mediates vision improvement after ocriplasmin treatment compared to a sham regimen.
• To quantify the direct and indirect effects of ocriplasmin on visual acuity and function through VMAR.

Main Methods:

• Causal mediation analysis applied to data from a randomized trial of 218 participants with vitreomacular traction.
• Logistic regression models used to estimate total treatment effect (TTE) on binary outcomes (visual acuity improvement, visual function questionnaire improvement, visual function improvement).
• Effects quantified as risk differences, breaking down TTE into indirect (via VMAR) and direct effects.

Main Results:

• Indirect effects of ocriplasmin on visual function questionnaire improvement (VFQ-I), visual acuity improvement (VA-I), and visual function improvement (VF-I) were 5.7%, 11.8%, and 5.2%, respectively.
• Direct effects of ocriplasmin on VFQ-I, VA-I, and VF-I were 5.7%, 11.8%, and 5.2%, respectively.
• Ocriplasmin's effect on VA-I was largely mediated by VMAR, while effects on VFQ-I and VF-I were only partially mediated.

Conclusions:

• VMAR plays a significant role in mediating vision benefits from ocriplasmin, particularly for visual acuity improvement.
• While ocriplasmin improves visual function, the contribution of VMAR to patient-reported outcomes is partial.
• Mediation analysis provides valuable insights into the mechanism of action for ocriplasmin in treating vitreomacular traction.